SCHEMBL7814801

SCHEMBL7814801

COc1ccc2[nH]cc(C3=C(c4cn(CCCN(C)C)c5ccc(OC)cc45)C(=O)NC3=O)c2c1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD1 Q15139 2/20 0.88
TDP1 Q9NUW8 2/20 0.88
GSK3B P49841 9/20 0.67
PRKACA P17612 5/20 0.67
PRKACG P22612 5/20 0.67
PRKACB P22694 5/20 0.67
PRKCA P17252 3/20 0.67
PIM1 P11309 2/20 0.67
PRKCB P05771 2/20 0.67
PRKCH P24723 2/20 0.67
PRKCQ Q04759 2/20 0.67
PRKCD Q05655 2/20 0.67
CCNB2 O95067 2/20 0.67
CDK1 P06493 2/20 0.67
CCNB1 P14635 2/20 0.67
CCNB3 Q8WWL7 2/20 0.67
CDK4 P11802 2/20 0.67
CCND1 P24385 2/20 0.67
MEN1 O00255 1/20 0.67
PRKD3 O94806 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9082920 0.94 PRKD1 (0.79) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL29525501 0.94 PRKD1 (1.00) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL29353099 0.94 PRKD1 (1.00) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL7823817 0.94 PRKD1 (0.87) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL1680253 0.94 PRKD1 (1.00) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL7815743 0.94 PRKD1 (0.78) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL9086409 0.91 PRKD1 (0.74) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL29041083 0.90 PRKD1 (0.92) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL9086359 0.89 PRKD1 (0.70) PRKD1TDP1GSK3BPRKACAPRKACG
SCHEMBL9087453 0.89 PRKD1 (0.70) PRKD1TDP1GSK3BPRKACAPRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP claimed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US claimed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP claimed
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP disclosed